W. Liu et Kj. Varner, CHARACTERIZATION OF THE SYMPATHETIC-NERVE RESPONSES TO AMPHETAMINE - ROLE OF CENTRAL ALPHA(2)-ADRENERGIC RECEPTORS, Journal of cardiovascular pharmacology, 28(5), 1996, pp. 712-722
Although amphetamine has profound cardiovascular actions, the role of
the sympathetic nervous system in these responses is largely unknown.
The purpose of this study was to characterize the sympathetic nerve re
sponses to amphetamine and to determine whether these neural responses
involve an action of amphetamine in the rostral ventrolateral medulla
(RVLM). In sinoaortically denervated (SAD) and sham-SAD rats, ampheta
mine dose-dependently increased mean arterial pressure (MAP) and heart
rate (HR), while decreasing (-87 +/- 5%; max) renal sympathetic nerve
discharge (SND) for 57 +/- 5 min. Comparison of the SND responses iu
SAD and sham-SAD rats revealed a small but significant contribution of
the baroreceptor reflex to the sympathoinhibitory response. In separa
te studies, the bilateral microinjection of amphetamine into RVLM decr
eased HX, MAP, and SND. The magnitude and duration of the decrease in
SND elicited by amphetamine were significantly attenuated by the prior
intravenous (i.v.) administration of idazoxan (alpha(2)-adrenergic an
tagonist). The prior bilateral microinjection of idazoxan or piperoxan
into RVLM significantly attenuated the duration of the sympathoinhibi
tory responses elicited by i.v. amphetamine. Idazoxan and piperoxan al
so tended to decrease the magnitude of the SND response; however, this
reduction was significant at only the highest doses. The MAP and HR r
esponses were unaffected by idazoxan treatment. The microinjection of
terazosin (alpha(1)-adrenergic antagonist) or propranolol (beta-adrene
rgic antagonist) into RVLM did not alter the HR, MAP, or SND responses
to i.v. amphetamine. We conclude that i.v. amphetamine decreases SND
in anesthetized rats, in large part, by a mechanism involving the acti
vation of alpha(2)-adrenergic receptors in RVLM.